MX9800603A - Use of ipriflavone to reduce the number of cd8+ cells. - Google Patents
Use of ipriflavone to reduce the number of cd8+ cells.Info
- Publication number
- MX9800603A MX9800603A MX9800603A MX9800603A MX9800603A MX 9800603 A MX9800603 A MX 9800603A MX 9800603 A MX9800603 A MX 9800603A MX 9800603 A MX9800603 A MX 9800603A MX 9800603 A MX9800603 A MX 9800603A
- Authority
- MX
- Mexico
- Prior art keywords
- cells
- ipriflavone
- reduce
- isopropoxyisoflavone
- lymphocytes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to pharmaceutical composition suitable to decrease the number of CD8+ cells comprising as active ingredient 7-isopropoxyisoflavone in admixture with suitable inert, solid or liquid carriers and optionally with usual therapeutic additives and auxiliary agents. The pharmaceutical compositions according to the invention are prepared by known methods and are suitable for the treatment of human or animal subjects being in a condition where selective suppression of CD8+ lymphocytes is desirable.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUP9502198 | 1995-07-21 | ||
| HU9502198A HU9502198D0 (en) | 1995-07-21 | 1995-07-21 | Novel indication |
| PCT/HU1996/000038 WO1997003664A1 (en) | 1995-07-21 | 1996-07-16 | Use of ipriflavone to reduce the number of cd8+ cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MXPA98000603A MXPA98000603A (en) | 1998-04-01 |
| MX9800603A true MX9800603A (en) | 1998-04-30 |
Family
ID=10987063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9800603A MX9800603A (en) | 1995-07-21 | 1996-07-16 | Use of ipriflavone to reduce the number of cd8+ cells. |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0841915A1 (en) |
| JP (1) | JP2001503371A (en) |
| KR (1) | KR19990028933A (en) |
| CN (1) | CN1191483A (en) |
| AR (1) | AR002905A1 (en) |
| AU (1) | AU6367096A (en) |
| BG (1) | BG102182A (en) |
| BR (1) | BR9610187A (en) |
| CA (1) | CA2227421A1 (en) |
| CZ (1) | CZ2798A3 (en) |
| EA (1) | EA199800146A1 (en) |
| EE (1) | EE9800020A (en) |
| HR (1) | HRP960345A2 (en) |
| HU (1) | HU9502198D0 (en) |
| IL (1) | IL122751A0 (en) |
| MX (1) | MX9800603A (en) |
| NO (1) | NO980127D0 (en) |
| PL (1) | PL324460A1 (en) |
| SK (1) | SK3298A3 (en) |
| WO (1) | WO1997003664A1 (en) |
| YU (1) | YU42796A (en) |
| ZA (1) | ZA966079B (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1241079B (en) * | 1990-03-23 | 1993-12-29 | Chiesi Farma Spa | PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE |
| HU212932B (en) * | 1993-08-02 | 1996-12-30 | Chinoin Gyogyszer Es Vegyeszet | Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition |
-
1995
- 1995-07-21 HU HU9502198A patent/HU9502198D0/en unknown
-
1996
- 1996-07-16 EA EA199800146A patent/EA199800146A1/en unknown
- 1996-07-16 CN CN96195722A patent/CN1191483A/en active Pending
- 1996-07-16 IL IL12275196A patent/IL122751A0/en unknown
- 1996-07-16 CZ CZ9827A patent/CZ2798A3/en unknown
- 1996-07-16 KR KR1019980700235A patent/KR19990028933A/en not_active Application Discontinuation
- 1996-07-16 CA CA002227421A patent/CA2227421A1/en not_active Abandoned
- 1996-07-16 MX MX9800603A patent/MX9800603A/en unknown
- 1996-07-16 JP JP50646497A patent/JP2001503371A/en active Pending
- 1996-07-16 PL PL96324460A patent/PL324460A1/en unknown
- 1996-07-16 EE EE9800020A patent/EE9800020A/en unknown
- 1996-07-16 AU AU63670/96A patent/AU6367096A/en not_active Abandoned
- 1996-07-16 BR BR9610187A patent/BR9610187A/en not_active Application Discontinuation
- 1996-07-16 EP EP96923004A patent/EP0841915A1/en not_active Withdrawn
- 1996-07-16 WO PCT/HU1996/000038 patent/WO1997003664A1/en not_active Application Discontinuation
- 1996-07-16 SK SK32-98A patent/SK3298A3/en unknown
- 1996-07-17 ZA ZA9606079A patent/ZA966079B/en unknown
- 1996-07-18 HR HRP9502198A patent/HRP960345A2/en not_active Application Discontinuation
- 1996-07-19 YU YU42796A patent/YU42796A/en unknown
- 1996-07-22 AR ARP960103677A patent/AR002905A1/en unknown
-
1998
- 1998-01-12 NO NO980127A patent/NO980127D0/en unknown
- 1998-01-14 BG BG102182A patent/BG102182A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR002905A1 (en) | 1998-04-29 |
| EE9800020A (en) | 1998-08-17 |
| SK3298A3 (en) | 1998-07-08 |
| KR19990028933A (en) | 1999-04-15 |
| AU6367096A (en) | 1997-02-18 |
| EP0841915A1 (en) | 1998-05-20 |
| CZ2798A3 (en) | 1998-06-17 |
| CA2227421A1 (en) | 1997-02-06 |
| BG102182A (en) | 1998-08-31 |
| IL122751A0 (en) | 1998-08-16 |
| NO980127L (en) | 1998-01-12 |
| JP2001503371A (en) | 2001-03-13 |
| HU9502198D0 (en) | 1995-09-28 |
| PL324460A1 (en) | 1998-05-25 |
| ZA966079B (en) | 1998-01-19 |
| EA199800146A1 (en) | 1998-08-27 |
| BR9610187A (en) | 1998-07-28 |
| YU42796A (en) | 1999-03-04 |
| WO1997003664A1 (en) | 1997-02-06 |
| NO980127D0 (en) | 1998-01-12 |
| HRP960345A2 (en) | 1998-02-28 |
| CN1191483A (en) | 1998-08-26 |
| WO1997003664A8 (en) | 1999-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20033131B (en) | Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity | |
| GEP20043161B (en) | Piperidines as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Modulators | |
| MX9307509A (en) | Method and pharmaceutical preparation to reduce cell activity. | |
| MX9702932A (en) | L-ribofuranosyl nucleosides. | |
| CA2388939A1 (en) | Therapeutic treatments for blood cell deficiencies | |
| CA2195419A1 (en) | Immunological activity of rhamnolipids | |
| MD1688G2 (en) | Benzothiophene, benzofuran and indolethiazepinons, oxazepinons and diazepinons, pharmaceutical composition, method of inhibiting the leucocytes adherence to the endothelial cells for inflammatory diseases treatment and method of treatment of the mammals affected by the HIV infection | |
| IL131811A0 (en) | Antitussive compositions | |
| ES8100883A1 (en) | Transdermal medication system for isosorbide dinitrate | |
| ITMI922331A1 (en) | USE OF PARATORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS AND RELATED PEPTIDES, FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION AND THERAPY OF ABORTION AND PRE-TERM BIRTH AND IN GENERAL FOR THE TREATMENT OF THE MANAGEMENT | |
| MY106231A (en) | Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones. | |
| MY104942A (en) | Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-ones. | |
| KR880007068A (en) | Use of 13-cis retinoic acid | |
| MX9800603A (en) | Use of ipriflavone to reduce the number of cd8+ cells. | |
| JPH06211636A (en) | Composition for oral cavity application | |
| MY106961A (en) | Antiviral tetrahydroimidazo[1,4] benzodiazepines | |
| UA41326C2 (en) | Pharmaceutical composition for prevention or treatment of viral diseases, means for prevention or treatment of viral diseases | |
| KR890012651A (en) | Diuretic or antihypertensive compositions | |
| WO2001013932A3 (en) | Stimulation of sperm function | |
| Mohammed | Peripheral, Pruritic, and Purpuric Eruptions Due to Prazosin | |
| IE780730L (en) | Veterinary composition | |
| MD218C2 (en) | Stimulator for hair growing | |
| MX9801192A (en) | Novel opioid peptides. |